Inhibitor ribonukleotidne reduktaze (Serbo-Croatian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Inhibitor ribonukleotidne reduktaze" in Serbo-Croatian language version.

refsWebsite

Global rank Serbo-Croatian rank

4^th place

3^rd place

2^nd place

610^th place

525^th place

low place

1^st place

6,663^rd place

1,410^th place

aspetjournals.org

Bernstein LR (1998). „Mechanisms of therapeutic activity for gallium”. Pharmacol. Rev. 50 (4): 665–682. PMID 9860806. Arhivirano iz originala na datum 2007-02-26. Pristupljeno 2014-07-08.

Zahedi Avval F, Berndt C, Pramanik A, Holmgren A (January 2009). „Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd)”. Biochem. Biophys. Res. Commun. 379 (3): 775–9. DOI:10.1016/j.bbrc.2008.12.128. PMID 19121624.
Mayhew CN, Phillips JD, Cibull ML, Elford HL, Gallicchio VS (September 2002). „Short-term treatment with novel ribonucleotide reductase inhibitors Trimidox and Didox reverses late-stage murine retrovirus-induced lymphoproliferative disease with less bone marrow toxicity than hydroxyurea”. Antivir. Chem. Chemother. 13 (5): 305–14. PMID 12630679.
Tsimberidou AM, Alvarado Y, Giles FJ (August 2002). „Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies”. Expert Rev Anticancer Ther 2 (4): 437–48. DOI:10.1586/14737140.2.4.437. PMID 12647987.
Bernstein LR (1998). „Mechanisms of therapeutic activity for gallium”. Pharmacol. Rev. 50 (4): 665–682. PMID 9860806. Arhivirano iz originala na datum 2007-02-26. Pristupljeno 2014-07-08.

Bernstein LR (1998). „Mechanisms of therapeutic activity for gallium”. Pharmacol. Rev. 50 (4): 665–682. PMID 9860806. Arhivirano iz originala na datum 2007-02-26. Pristupljeno 2014-07-08.